Sex steroid priming for induction of puberty in thalassemia patients with pulsatile reversible hypogonadotrophic hypogonadism

Hemoglobin

Volumn 35, Issue 5-6, 2011, Pages 659-664

  Chatterjee, Ratna ^a   Mukhopadhyay, Tarak Nath ^b   Chandra, Sharmila ^b   Bajoria, Rekha ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b VIVEKANANDA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Growth; Growth hormone; Puberty; Reversible pulsatile hypogonadotrophic hypogonadism (HH); Sex steroid priming; Thalassemia

Indexed keywords

ETHINYLESTRADIOL; ETHISTERONE; IRON; MEDROXYPROGESTERONE; TESTOSTERONE PROPIONATE;

ADOLESCENT; ADULT; ARTICLE; FEMALE; GROUPS BY AGE; GROWTH ACCELERATION; GROWTH RETARDATION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INDIAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PUBERTY; PUBERTY DISORDERS; PULSATILE REVERSIBLE HYPOGONADOTROPIC HYPOGONADISM; STUNTING; THALASSEMIA MAJOR; TREATMENT RESPONSE;

ADOLESCENT; BETA-THALASSEMIA; ETHINYL ESTRADIOL; HUMANS; HYPOGONADISM; PUBERTY, DELAYED; TESTOSTERONE PROPIONATE; TREATMENT OUTCOME;

EID: 81055144340     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2011.630121     Document Type: Article

References (12)

1. Chatterjee R, Bajoria R. Critical appraisal of growth retardation and pubertal disturbances in thalassemia. Ann NY Acad Sci. 2010;1202:100-114.
2. Dubey AP, Parakh A, Dublish S. Current trends in the management of β thalassemia. Indian J Pediatr. 2008;75(7):739-743.
3. Chatterjee R, Bajoria R. Osteopenia-osteoporosis syndrome in patients with thalassemia: understanding of type of bone disease and response to treatment. Hemoglobin. 2009;33(S1):S136-S138.
4. Bajoria R, Chatterjee R. Current perspectives of fertility and pregnancy in thalassemia. Hemoglobin. 2009;33(S1):S131-135.
5. Chatterjee R, Katz M, Cox T, Bantock H. Evaluation of growth hormone in thalassaemic boys with failed puberty: spontaneous versus provocative test. Eur J Pediatr. 1993;152(9):721-726. (Pubitemid 23257903)
6. Soliman AT, ElZalabany M, Amer M, Ansari BM. Growth and pubertal development in transfusiondependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study. J Trop Pediatr. 1999;45(1):23-30. (Pubitemid 29094914)
7. Chatterjee R, Katz M. Evaluation of gonadotrophin insufficiency in thalassemic boys with pubertal failure: spontaneous versus provocative test. J Pediatr Endocrinol Metabol. 2001;14(3):301-312. (Pubitemid 32229763)
8. Chatterjee R, Katz M, Oatridge A, et al. Selective loss of anterior pituitary volume with severe pituitary-gonadal insufficiency in poorly compliant male thalassemic patients with pubertal rrest. Ann NY Acad Sci. 1998;850:479-482. (Pubitemid 28369810)
9. Kyriakou A, Skordis N. Thalassaemia and aberrations of growth and puberty. Mediterr J Hematol Infect Dis. 2009;1(1):1-14.
10. De Virgiliis S, Congia M, Frau F, et al. Deferoxamine-induced growth retardation in patients with thalassemia major. J Pediatr. 1988;113(4):661-669.
11. Chatterjee R, Katz M. Reversible hypogonadotrophic hypogonadism in sexually infantile male thalassaemic patients with transfusional iron overload. Clin Endocrinol (Oxford). 2000;53(1):33-42. (Pubitemid 30646124)
12. Chatterjee R, Katz M, Wonke B, Hoffbrand AV. Induction of puberty in patients with β-thalassemia major. Birth Defects Orig Artic Ser. 1987;23(5A):453-458.